<DOC>
	<DOCNO>NCT00747149</DOCNO>
	<brief_summary>This study ass customize start dose rosuvastatin appropriate degree LDL-C reduction require , would achieve LDL-C target ≤ 2.0 mmol/L quickly either titration one titration step 6 week therapy type 2 diabetic patient previously treat another statin LDL-C target .</brief_summary>
	<brief_title>A Diabetes Study Treat A Population Previously Not Target</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Diagnosis Type 2 diabetes Previously treat commonly accepted start dose statin last 4 week prior study entry Fasting LDLC concentration &gt; 2.0 mmol/L ( ≤ 5.0 mmol/L ) ( past 3 month ) History serum TG level ≤ 4.6 mmol/l ( past 3 month ) If currently receive therapy statin dose higher list Rosuvastatin ( current use ) Fibrates , niacin resin discontinue minimum 2 month prior enrolment . Type 1 diabetes ; glycated haemoglobin ( HbA1c ) &gt; 9.0 % Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) level ≥ 1.5 × upper limit normal ( ULN ) ( past 2 month ) Resting diastolic systolic blood pressure &gt; 95 mmHg &gt; 180 mmHg , respectively ( past 2 month ) Unexplained serum creatine kinase ( CK ) level &gt; 3 × ULN ( past 2 month ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>diabetes</keyword>
	<keyword>type 2</keyword>
</DOC>